NEUMORA THERAPEUTICS, INC. Operating Lease, Liability, Current
NEUMORA THERAPEUTICS, INC. (NMRA) had Operating Lease, Liability, Current of $299.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $299.00K.
- 2026-03-31: Operating Lease, Liability, Current $291.00K.
- 2025-12-31: Operating Lease, Liability, Current $284.00K.
- 2025-09-30: Operating Lease, Liability, Current $256.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $299.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $291.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $284.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $256.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $171.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $938.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.85M 10-K · filed 2026-03-30 |
| 2024-09-30 | $2.75M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.61M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $3.49M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.38M 10-K · filed 2025-03-03 |
| 2023-09-30 | $3.40M 10-Q · filed 2023-11-01 |
| 2022-12-31 | $3.37M 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |